1. Home
  2. ANIX vs RFM Comparison

ANIX vs RFM Comparison

Compare ANIX & RFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$3.39

Market Cap

108.5M

Sector

Health Care

ML Signal

HOLD

Logo RiverNorth Flexible Municipal Income Fund Inc.

RFM

RiverNorth Flexible Municipal Income Fund Inc.

HOLD

Current Price

$14.94

Market Cap

89.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIX
RFM
Founded
1982
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
108.5M
89.3M
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ANIX
RFM
Price
$3.39
$14.94
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$8.67
N/A
AVG Volume (30 Days)
282.9K
12.1K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
12.82
N/A
EPS
N/A
N/A
Revenue
$210,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.32
$13.68
52 Week High
$5.46
$15.03

Technical Indicators

Market Signals
Indicator
ANIX
RFM
Relative Strength Index (RSI) 62.87 67.45
Support Level $2.90 $14.22
Resistance Level $3.53 N/A
Average True Range (ATR) 0.28 0.11
MACD 0.05 0.01
Stochastic Oscillator 79.92 83.21

Price Performance

Historical Comparison
ANIX
RFM

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

About RFM RiverNorth Flexible Municipal Income Fund Inc.

RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.

Share on Social Networks: